• Je něco špatně v tomto záznamu ?

Biochemical insight into soman intoxication and treatment with atropine, HI-6, trimedoxime, and K203 in a rat model

M. Pohanka, J. Pikula, K. Kuca, J. Kassa,

. 2011 ; 112 (10) : 539-44.

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12028037

OBJECTIVE: The present experiment is based on biochemical assessment of nerve agent soman intoxication and atropine, respectively atropine and HI-6, trimedoxime or K203 treatment in rats. BACKGROUND: Nerve agents are toxic substances irreversibly inhibiting enzyme acetylcholinesterase (AChE). Treatment is typically based on application of atropine and oxime reactivator. Atropine is able to protect overstimulation of muscarinic acetylcholine receptors. Application of oxime reactivator enable return of AChE activity and full suppression of intoxication. METHODS: In a total, fifteen biochemical markers were assayed in plasma or blood of intoxicated animals. 42 rats were divided into 7 groups each 6 individuals. The first group was exposed to atropine; the second group was exposed to one LD50 of soman and atropine. The groups 3-5 were exposed in a same way as the second group and were treated with oxime reactivators: HI-6 (group 3), trimedoxime (4) and K203 (5). The sixth group was control treated with saline solution only. The last (seventh) group was intoxicated with soman only. RESULTS: The most striking shifts were found for blood acetylcholinesterase and plasma creatinine, glucose, inorganic phosphate as well as uric acid. Lactate dehydrogenase and aspartate aminotransferase assays were useless due to soman interference. CONCLUSION: It was demonstrated that treatment was able to protect poisoned animals from metabolic disorder represented by hyperglycemia and nephropathy represented by hyperuricemia and elevated creatinine. Soman exposure and treatment with the oxime reactivators and/or atropine contains quite complex and still not well understood side mechanisms (Tab. 2, Fig. 1, Ref. 25).

000      
00000naa a2200000 a 4500
001      
bmc12028037
003      
CZ-PrNML
005      
20121206122700.0
007      
ta
008      
120817s2011 xo f 000 0#eng||
009      
AR
035    __
$a (PubMed)21954536
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Pohanka, M $u Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic. miroslav.pohanka@gmail.com
245    10
$a Biochemical insight into soman intoxication and treatment with atropine, HI-6, trimedoxime, and K203 in a rat model / $c M. Pohanka, J. Pikula, K. Kuca, J. Kassa,
520    9_
$a OBJECTIVE: The present experiment is based on biochemical assessment of nerve agent soman intoxication and atropine, respectively atropine and HI-6, trimedoxime or K203 treatment in rats. BACKGROUND: Nerve agents are toxic substances irreversibly inhibiting enzyme acetylcholinesterase (AChE). Treatment is typically based on application of atropine and oxime reactivator. Atropine is able to protect overstimulation of muscarinic acetylcholine receptors. Application of oxime reactivator enable return of AChE activity and full suppression of intoxication. METHODS: In a total, fifteen biochemical markers were assayed in plasma or blood of intoxicated animals. 42 rats were divided into 7 groups each 6 individuals. The first group was exposed to atropine; the second group was exposed to one LD50 of soman and atropine. The groups 3-5 were exposed in a same way as the second group and were treated with oxime reactivators: HI-6 (group 3), trimedoxime (4) and K203 (5). The sixth group was control treated with saline solution only. The last (seventh) group was intoxicated with soman only. RESULTS: The most striking shifts were found for blood acetylcholinesterase and plasma creatinine, glucose, inorganic phosphate as well as uric acid. Lactate dehydrogenase and aspartate aminotransferase assays were useless due to soman interference. CONCLUSION: It was demonstrated that treatment was able to protect poisoned animals from metabolic disorder represented by hyperglycemia and nephropathy represented by hyperuricemia and elevated creatinine. Soman exposure and treatment with the oxime reactivators and/or atropine contains quite complex and still not well understood side mechanisms (Tab. 2, Fig. 1, Ref. 25).
650    _2
$a zvířata $7 D000818
650    _2
$a antidota $x terapeutické užití $7 D000931
650    _2
$a atropin $x terapeutické užití $7 D001285
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a chemické bojové látky $x otrava $7 D002619
650    _2
$a cholinesterasové inhibitory $x otrava $7 D002800
650    _2
$a reaktivátory cholinesterasy $x terapeutické užití $7 D002801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a oximy $x terapeutické užití $7 D010091
650    _2
$a pyridinové sloučeniny $x terapeutické užití $7 D011726
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a soman $x otrava $7 D012999
650    _2
$a trimedoxim $x terapeutické užití $7 D014289
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pikula, J
700    1_
$a Kuca, K
700    1_
$a Kassa, J
773    0_
$w MED00000845 $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 112, č. 10 (2011), s. 539-44
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21954536 $y Pubmed
910    __
$a ABA008 $b A 4 $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121206122734 $b ABA008
999    __
$a ok $b bmc $g 950079 $s 785383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 112 $c 10 $d 539-44 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
LZP    __
$a Pubmed-20120817/11/04

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace